Kevin Horgan

Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial

Robert S. Bresalier, Robert S. Sandler, Hui Quan et al. · New England Journal of Medicine · 2005 · 2.5K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells.

G A van Seventer, Yoji Shimizu, Kevin Horgan et al. · The Journal of Immunology · 1990 · 791 citations · Full text

Life Sciences, Cell Biology, Immunology +16

The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group

Paul J. Hesketh, Steven M. Grunberg, Richard J. Gralla et al. · Journal of Clinical Oncology · 2003 · 776 citations

Medicine, Pharmacology, Pharmacotherapy +17

Regulated expression and binding of three VLA (β1) integrin receptors on T cells

Yoji Shimizu, Gijs A. van Seventer, Kevin Horgan et al. · Nature · 1990 · 630 citations

Life Sciences, Cell Biology, Molecular Biology +14

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy‐induced nausea and vomiting

S. Poli-Bigelli, José Rodrigues-Pereira, Alexandra D. Carides et al. · Cancer · 2003 · 566 citations

Medicine, Oncology, Pharmacology +17